UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Germline gene therapy: We're ready

Science (American Association for the Advancement of Science), 2015-06, Vol.348 (6241), p.1325-1325

Miller, Henry I.

2015

Volltextzugriff (PDF)

Will the Biden administration 'follow the science' on regulatory reform?

Nature biotechnology, 2021-11, Vol.39 (11), p.1334-1335

2021

Volltextzugriff (PDF)

Recasting Asilomar's lessons for human germline editing

Nature biotechnology, 2015-11, Vol.33 (11), p.1132-1134

Miller, Henry I

2015

Volltextzugriff (PDF)

US Congress mandates silliness, USDA complies

Nature biotechnology, 2019-05, Vol.37 (5), p.497-498

2019

Volltextzugriff (PDF)

We Can use Market Forces to Moderate Drug Prices

Missouri medicine, 2019-11, Vol.116 (6), p.451-453

Miller, Henry I

2019

Volltextzugriff (PDF)

A Plea for the Renewal of the ISBR

Trends in biotechnology (Regular ed.), 2018-03, Vol.36 (3), p.229-231

2018

Volltextzugriff (PDF)

FDA's 'Accelerated Approvals' Are Critical But Raise Thorny Issues

Missouri medicine, 2019-05, Vol.116 (3), p.168-169

Miller, Henry I

2019

Volltextzugriff (PDF)

Basic research is often best appreciated in retrospect

Nature biotechnology, 2014-01, Vol.32 (1), p.24-25

Miller, Henry I

2014

Volltextzugriff (PDF)

Buying 'Organic' to Get 'Authenticity'? Or Safer and More Nutritious Food? Think Again. And Again

Missouri medicine, 2019-01, Vol.116 (1), p.8-11

Miller, Henry I

2019

Volltextzugriff (PDF)

FDA is the wrong agency to regulate genetically engineered animals

Nature biotechnology, 2017-07, Vol.35 (7), p.620-622

2017

Volltextzugriff (PDF)

What's behind a 'genetically engineered' label?

Nature biotechnology, 2015-05, Vol.33 (5), p.451-453

2015

Volltextzugriff (PDF)

Genetic engineering applied to agriculture has a long row to hoe

GM crops & food, 2018-01, Vol.9 (1), p.45-48

Miller, Henry I

2018

Volltextzugriff (PDF)

Patients Suffer While the Science Establishment Resists Innovative Therapies

Journal of commercial biotechnology, 2018-04, Vol.24 (2), p.6

Miller, Henry I

2018

Volltextzugriff (PDF)

USDA Reorganization Should Reduce Biotech Regulation and Feds’ Involvement in the Organic Industry

Journal of commercial biotechnology, 2020-01, Vol.25 (1), p.3

2020

Volltextzugriff (PDF)

Personalized Medicine Needs Enlightened Regulation To Realize Its Potential

Journal of commercial biotechnology, 2017-10, Vol.23 (4), p.3

Miller, Henry I

2017

Volltextzugriff (PDF)

Could COVID-19 Cause ‘Biopharming’ to Bloom?

Journal of commercial biotechnology, 2020-07, Vol.25 (3), p.34-36

2020

Volltextzugriff (PDF)

The tarnished gold standard for GM risk assessment

GM crops & food, 2010-03, Vol.1 (2), p.59-61

Miller, Henry I.

2010

Volltextzugriff (PDF)

Why an abbreviated FDA pathway for biosimilars is overhyped

Nature biotechnology, 2011-09, Vol.29 (9), p.794-795

Miller, Henry I

2011

Volltextzugriff (PDF)

The regulation of agricultural biotechnology: science shows a better way

New biotechnology, 2010-11, Vol.27 (5), p.628-634

Miller, Henry I.

2010

Volltextzugriff (PDF)

Flawed scientific studies block progress and sow confusion

GM crops & food, 2020-07, Vol.ahead-of-print (ahead-of-print), p.1-5

2020

Volltextzugriff (PDF)

The UN's water torture

GM crops & food, 2010-01, Vol.1 (1), p.13-15

Miller, Henry I.

2010

Volltextzugriff (PDF)

The U.N. celebrates a regulatory debacle

GM crops & food, 2018-10, Vol.9 (4), p.169-172

2018

Volltextzugriff (PDF)

The flower industry gets the genetic engineering blues

GM crops & food, 2018-01, Vol.9 (2), p.49-52

2018

Volltextzugriff (PDF)

Germline Gene Therapy: Don't Let Good Intentions Spawn Bad Policy

Issues in science and technology, 2016-04, Vol.32 (3), p.57-60

MILLER, HENRY I.

2016

Volltextzugriff (PDF)

The 'Future of Food" is Genetic Engineering

Journal of commercial biotechnology, 2018-07, Vol.24 (3), p.3

Wager, Robert

2018

Volltextzugriff (PDF)

1 – 25 von 4.910

Menü

Weitere Dienste

Einstellungen

Germline gene therapy: We're ready

Will the Biden administration 'follow the science' on regulatory reform?

Recasting Asilomar's lessons for human germline editing

US Congress mandates silliness, USDA complies

We Can use Market Forces to Moderate Drug Prices

A Plea for the Renewal of the ISBR

FDA's 'Accelerated Approvals' Are Critical But Raise Thorny Issues

Basic research is often best appreciated in retrospect

Buying 'Organic' to Get 'Authenticity'? Or Safer and More Nutritious Food? Think Again. And Again

FDA is the wrong agency to regulate genetically engineered animals

What's behind a 'genetically engineered' label?

Genetic engineering applied to agriculture has a long row to hoe

Patients Suffer While the Science Establishment Resists Innovative Therapies

USDA Reorganization Should Reduce Biotech Regulation and Feds’ Involvement in the Organic Industry

Personalized Medicine Needs Enlightened Regulation To Realize Its Potential

Could COVID-19 Cause ‘Biopharming’ to Bloom?

The tarnished gold standard for GM risk assessment

Why an abbreviated FDA pathway for biosimilars is overhyped

The regulation of agricultural biotechnology: science shows a better way

Flawed scientific studies block progress and sow confusion

The UN's water torture

The U.N. celebrates a regulatory debacle

The flower industry gets the genetic engineering blues

Germline Gene Therapy: Don't Let Good Intentions Spawn Bad Policy

The 'Future of Food" is Genetic Engineering

Suchergebnisse filtern